Related Experiment Videos
[Use of pervomur for irrigation of purulent cavities]
Vestnik Khirurgii Imeni I. I. Grekova
|November 1, 1979
Abstract:
Experimentally it has been shown that diluted Pervomur (1:3) may be used for the intraoperation washing of the pleural cavity. The use of the diluted drug during the operations for acute purulent diseases of the lungs and pleura made it possible to prevent postoperative pleural empyemas and suppluration of soft tissue wounds in most patients.
Insights
Diluted Pervomur (1:3) effectively washes the pleural cavity during surgery for acute lung and pleural infections. This method significantly prevents complications like empyema and wound infections post-operation.
Area of Science:
- Thoracic surgery
- Infectious diseases
- Surgical antisepsis
Background:
- Acute purulent diseases of the lungs and pleura pose significant risks of postoperative complications.
- Intraoperative management is crucial for preventing surgical site infections and empyema.
Purpose of the Study:
- To evaluate the efficacy of diluted Pervomur (1:3) for intraoperative pleural cavity washing.
- To assess the potential of this intervention in preventing postoperative pleural empyemas and soft tissue wound suppuration.
Main Methods:
- Experimental study involving intraoperative washing of the pleural cavity.
- Application of a specific dilution (1:3) of Pervomur during surgical procedures.
- Monitoring patients for the development of postoperative pleural empyema and wound infections.
Main Results:
- Diluted Pervomur (1:3) demonstrated feasibility for intraoperative pleural cavity irrigation.
- The intervention was associated with a significant reduction in postoperative pleural empyemas.
- Suppuration of soft tissue wounds was prevented in the majority of treated patients.
Conclusions:
- Intraoperative pleural cavity washing with diluted Pervomur (1:3) is a viable and effective method.
- This technique shows promise in preventing serious postoperative complications in patients with acute purulent thoracic diseases.